To break it down: The first part, HER2, stands for “human epidermal growth factor receptor 2”. This refers to a protein found on the surface of breast cells that helps direct how quickly those ...

Cite this: The Role of Hormonal Therapy in the Management of Hormonal-Receptor-Positive Breast Cancer With Co-Expression of HER2 - Medscape - Sep 01, 2008. The article is based primarily on a ...

Both rare and aggressive, triple-negative breast cancer accounts for 10-15% of all breast cancers. Dr. Bhardwaj says, “TNBC ...

HER2-positive (HER2+) breast cancer is a type of breast cancer that tests positive for human epidermal growth factor receptor 2 (HER2), a protein that promotes cancer cell growth. It tends to be ...

An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...

Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence: Basel Thursday, November 28, 2024, 09: ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.